ALTUVIIIO
Active substance: antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
KIT · antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
United StatesActive
Marketing holder: Bioverativ Therapeutics Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
Registration
- Registration number
- 71104-982
- Registration status
- Active
- Dispensing
- Prescription only
Sources
- product · openFDA NDC · 71104-982 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 71104-982 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 71104-982 · Verified 2026-10-09 · open in source